Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Sao Paulo General Hospital

About this trial

This randomized, double-blind, placebo-controlled clinical trial aims to evaluate whether single-dose amoxicillin prophylaxis administered prior to simple tooth extraction reduces postoperative infection rates inpatients with autoimmune rheumatic diseases (ARDs).

Although antibiotic prophylaxis is not recommended for healthy individuals undergoing simple extractions, immunosuppressed ARD patients frequently receive antibiotics despite limited evidence supporting this practice.

Secondary objectives include assessing infection severity, postoperative complications, and the impact of ARD diagnosis and immunosuppressive treatment on infection risk.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years

Confirmed diagnosis of an ARD: SLE, RA, JIA, AS, PsA, IIM, systemic vasculitis, primary Sjögren's syndrome, or SSc

Use of prednisone and/or at least one synthetic immunosuppressant (methotrexate, azathioprine, mycophenolate mofetil, leflunomide, cyclophosphamide, cyclosporine, or tacrolimus), immunobiological agent or immunomodulator (chloroquine, sulfasalazine), with no plans to switch medications.

Indication for simple tooth extraction with chronic odontogenic focus

Disqualifiers

Individuals who do not agree to participate in the study will be excluded.

Patients requiring extractions that are more complex from a technical standpoint, such as impacted third molars.

Patients with local or systemic conditions requiring more extensive antibiotic coverage, such as cases with clinical signs of acute infections, patients on anticoagulant therapy, patients with heart disease, patients who have undergone radiation therapy, or patients currently being treated for neoplasms;

Patients allergic to amoxicillin.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Amoxicillin

    Drug

    Amoxicillin 2 g a single prophylactic dose prior to simple extraction.

  • Placebo

    Other intervention

    Matching placebo tablets administered as a single dose prior to extraction

Treatment groups

352 Participants
are divided into 2 treatment groups
Group A: Arm 1 - Antibiotic ProphylaxisActive comparator 1 intervention
Group B: Arm 2 - No Antibiotic ProphylaxisPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Frequency of postoperative infections

Proportion of participants developing postoperative infection, defined as purulent/serous exudate, fever, or clinical signs of local infection.

Time frame
7 days post-extraction

Secondary outcomes

1

Incidence of Postoperative Complications

Presence of alveolitis, fever, edema, erythema, trismus, exudate, and pain between the two groups

Time frame
7 days post-extraction
2

Severity and Duration of Infection

To compare the duration and severity of the infection and any possible differences between the two groups

Time frame
7 days post-extraction
3

impact of demographic data, different ARDs; disease activity, and treatment

Compare the potential impact of demographic data, different ARDs; and treatment on the frequency and severity of infection in the two groups;

Time frame
7 days post-extraction
4

Oral Health in the different ARDs

Characterize oral health in the different ARDs using the decayed, missing, or filled teeth index (DMF) and the simplified periodontal screening and recording (PSR).

Time frame
Day 1

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Sao Paulo General Hospital

Lead sponsor

Fundação de Amparo à Pesquisa do Estado de São Paulo

Collaborator

This trial is not recruiting at the moment. You can still explore other options: